Gabapentin: An alternative to the cyclooxygenase-2 inhibitors for perioperative pain management

Anesthesia and Analgesia

Volumn 102, Issue 1, 2006, Pages 175-181

  Turan, A ^a   White, P F ^b   Karamanlioglu B ^a   Memis, D ^a   Tasdogan M ^a   Pamukcu Z ^a   Yavuz, E ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ATRACURIUM; ATROPINE; CELECOXIB; COCODAMOL; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; GABAPENTIN; MIDAZOLAM; MORPHINE; NEOSTIGMINE; NITROUS OXIDE; ONDANSETRON; OPIATE; PARACETAMOL; PARECOXIB; PLACEBO; PREGABALIN; PROPOFOL; ROFECOXIB; SEVOFLURANE; VALDECOXIB;

ABDOMINAL HYSTERECTOMY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DAILY LIFE ACTIVITY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG CAPSULE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG UTILIZATION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; PERIOPERATIVE PERIOD; PERIPHERAL EDEMA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SHORT COURSE THERAPY; SOMNOLENCE; URINE RETENTION; XEROSTOMIA;

EID: 29844444047     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000184824.43411.63     Document Type: Article

References (26)

1. Kehlet H, Mogensen T. Hospital stay of 2 days after open sigmoidectomy with a multimodal rehabilitation programme. Br J Surg 1999;86:227-30.
2. Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000;91:1221-5.
3. Issioui T, Klein KW, White PF, et al. Cost-efficacy of rofecoxib versus acetaminophen for preventing pain after ambulatory surgery. Anesthesiology 2002;97:931-7.
4. Turan A, Emet S, Karamanlioglu B et al. Analgesic effects of rofecoxib in ear-nose-throat surgery. Anesth Analg 2002;95:1308-11.
5. Buvanendran A, Kroin JS, Tuman KJ et al. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomised controlled trial. JAMA 2003;290:2411-8.
6. Ma H, Tang J, White PF, et al. Perioperative rofecoxib improves early recovery after outpatient herniorrhaphy. Anesth Analg 2004;98:970-5.
7. Sinatra RS, Shen QJ, Halaszynski T, et al. Preoperative rofecoxib oral suspension as an analgesic adjunct after lower abdominal surgery: the effects on effort-dependent pain and pulmonary function. Anesth Analg 2004;98:135-40.
8. Karamanlioglu B, Turan A, Memis D, Ture M. Preoperative oral rofecoxib reduces postoperative pain and tramadol consumption in patients after abdominal hysterectomy. Anesth Analg 2004;98:1039-43.
9. Rosner H, Rubin L, Kestenbaum A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain 1996;12:56-8.
10. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomised controlled trial. JAMA 1998;280:1831-6.
11. Dahl JB, Mathiesen O, Moiniche S. Protective premedication: an option with gabapentin and related drugs? A review of gabapentin and pregabalin in the treatment of post-operative pain. Acta Anaesthesiol Scand 2004;48:1130-6.
12. Feng Y, Cui M, Willis WD. Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 2003;98:729-33.
13. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q. The analgesic effect of gabapentin and mexiletine after breast surgery for cancer. Anesth Analg 2002;95:985-91.
14. Dirks J, Fredensborg BB, Christensen D, et al. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology 2002;97:560-4.
15. Turan A, Karamanlioglu B, Memis D, et al. Analgesic effects of gabapentin after spinal surgery. Anesthesiology 2004;100:935-8.
16. Turan A, Memis D, Karamanlioglu B, et al. The analgesic effects of gabapentin in monitored anesthesia care for ear-nose-throat surgery. Anesth Analg 2004;99:375-8.
17. Myles PS, Hunt JO, Nightingale CE, et al. Development and psychometric testing of a quality of recovery score after general anesthesia and surgery in adults. Anesth Analg 1999;88:83-90.
18. Ott E, Nussmeier NA, Duke PC, et al. Efficacy and safety of the cyclooxygenase 2-inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003;125:1481-92.
19. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005;352:1-11.
20. Issioui T, Klein KW, White PF, et al. The efficacy of premedication with celecoxib and acetaminophen in preventing pain after otolaryngologic surgery. Anesth Analg 2002;94:1188-93.
21. Watcha MF, Issioui T, Klein KW, White PF. Costs and effectiveness of rofecoxib, celecoxib and acetaminophen for preventing pain after ambulatory otolaryngologic surgery. Anesth Analg 2003;96:987-94.
22. Recart A, Issioui T, White PF, et al. The efficacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: a dose-ranging study. Anesth Analg 2003;96:1631-5.
23. Kroin JS, Buvanendran A, McCarthy RJ, et al. Cyclooxygenase-2 inhibition potentiates morphine antinociception at the spinal level in a postoperative pain model. Reg Anesth Pain Med 2002;27:451-5.
24. Gilron I, Orr E, Tu D, et al. A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy. Pain 2005;113:191-200.
25. White PF. Changing role of COX-2 inhibitors in the perioperative period: Is parecoxib really the answer? Anesth Analg 2005;100:1306-8.
26. Muscas GC, Chivoli S, Luceri F, et al. Conversion from thrice daily to twice daily administration of gabapentin in partial epilepsy; analysis of clinical efficacy and plasma levels. Seizure 2000;9:47-50.